Evidence brief · printable

Asthma evidence brief

One page, every section sourced. Print it or bring it on your phone.

Print or save as PDF Fits on one A4 or Letter page.

Asthma: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 1,668 matching trials) · https://research.opensourcemed.info/briefs/asthma.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Mometasone furoate 2 trials
  • Administration of inhaled tiotropium bromide 1 trial
  • AER 001 1 trial
  • Alfacalcidol 1 trial
  • ASMANEX TWISTHALER 1 trial
  • BENRALIZUMAB 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Education, coaching and self-management 104 trials · 62 completed · 15 with results
  • Vitamin D 18 trials · 14 completed · 10 with results
  • Care coordination, navigation and outreach 28 trials · 21 completed · 9 with results
  • Behavioural treatment for alcohol, smoking and drug use 4 trials · 3 completed · 3 with results
  • Breathing and respiratory muscle training 57 trials · 35 completed · 2 with results
  • Aerobic and endurance exercise 17 trials · 6 completed · 1 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Probiotics
  • Vitamin D3
  • Magnesium
  • Vitamin E
  • Pycnogenol
  • Moringa

Biomarkers reported

Direction in patients compared with the stated comparison group, as reported in the cited study.

  • Blood Eosinophil Count higher · Bacharier et al. 2024
  • Eotaxin higher · Whittle et al. 2019
  • Fractional Exhaled Nitric Oxide (FeNO) higher · Loewenthal et al. 2022
  • Interleukin-13 higher · Okuyama et al. 2014
  • Interleukin-5 higher · Lucas et al. 2020
  • Periostin higher · Sonnenberg-Riethmacher et al. 2021

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • A Study of HB0056 in Adult Participants With Moderate to Severe Asthma NCT07899996
  • Roll-over Study for Participants Who Have Completed a Previous Clinical Study With… NCT07444567
  • Rademikibart IV for Acute Asthma and COPD Exacerbation NCT07705737
  • Individualizing Treatment for Asthma in Primary Care (Full Study) NCT07052942
  • Reducing Overuse of Antibiotics With Decision Support NCT06788093
  • CHEST: A Collaboration With Community HEalth Centers to Implement SmarT for Asthma NCT07241117

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Exercise and physical activity: physical function and exercise capacity 25 trials, no results posted yet
  • Breathing and respiratory training: quality of life 15 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (462 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page · biomarker atlas. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.